{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:42:53Z","timestamp":1790048573797,"version":"4.0.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0973-1482.170530","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T01:42:45Z","timestamp":1448502165000},"page":"244","source":"Crossref","is-referenced-by-count":9,"title":["Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma"],"prefix":"10.4103","volume":"11","author":[{"given":"Linfa","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoucong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heqing","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.170530-1","first-page":"1167","volume-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"key":"key-10.4103\/0973-1482.170530-2","first-page":"1","volume-title":"American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules","author":"Gharib","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"key-10.4103\/0973-1482.170530-3","unstructured":"Hao J, Chen W. Chinese Cancer Registry Annual Report 2012. Beijing: Military Medical Sciences Press; 2012. p. 27-9."},{"key":"key-10.4103\/0973-1482.170530-4","first-page":"264","volume-title":"Guidelines for 131 I therapy on differentiated thyroid cancer (2014 edition)","author":"Chinese","year":"2014","journal-title":"Chin J Nucl Med Mol Imaging"},{"key":"key-10.4103\/0973-1482.170530-5","first-page":"1362","volume-title":"Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma","author":"Muratet","year":"1997","journal-title":"J Nucl Med"},{"key":"key-10.4103\/0973-1482.170530-6","first-page":"428","volume-title":"A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131 I and review of the literature: Implications for sequential treatments","author":"Leger","year":"2005","journal-title":"Br J Radiol"},{"key":"key-10.4103\/0973-1482.170530-7","first-page":"499","volume-title":"Radioiodine-131 in differentiated thyroid cancer: A retrospective analysis of an uptake-related ablation strategy","author":"Verkooijen","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key-10.4103\/0973-1482.170530-8","first-page":"673","volume-title":"The absorbed dose to the blood is a better predictor of ablation success than the administered 131 I activity in thyroid cancer patients","author":"Verburg","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key-10.4103\/0973-1482.170530-9","first-page":"249","volume-title":"Analysis of influential factors for efficacy of 131 I thyroid remnant ablation for differentiated thyroid cancer","author":"Fu","year":"2010","journal-title":"J Shanghai Jiaotong Univ (Med Sci)"},{"key":"key-10.4103\/0973-1482.170530-10","first-page":"556","volume-title":"Efficacy and influencing factors of radioactive 131 I for elimination of thyroid remnants following differentiated thyroid carcinoma resection","author":"Liu","year":"2013","journal-title":"Chin Remedies Clin"},{"key":"key-10.4103\/0973-1482.170530-11","first-page":"117","volume-title":"Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations","author":"Na","year":"2012","journal-title":"Korean J Radiol"},{"key":"key-10.4103\/0973-1482.170530-12","first-page":"335","volume-title":"Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study","author":"Baek","year":"2012","journal-title":"Radiology"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:35:02Z","timestamp":1786649702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0973-1482.170530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"alternative-id":["170530"],"URL":"https:\/\/doi.org\/10.4103\/0973-1482.170530","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}